Synovial tissue inflammation markers

The term "Synovial tissue inflammation markers" encompasses a set of protein and cellular biomarkers that are commonly analyzed in inflamed joints, especially in diseases such as rheumatoid arthritis. These markers include but are not limited to cellular surface molecules (e.g., CD55, CD68, CD163, CD248, podoplanin), enzymes (e.g., matrix metalloproteinases like MMP-3), and soluble inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, IL-8). They are expressed by various synovial cell types including macrophages, fibroblast-like synoviocytes, and infiltrating lymphocytes, and can be used to assess inflammation severity, stratify disease subtypes, monitor treatment response, and in some cases act as therapeutic targets or predictors of clinical outcome. However, "Synovial tissue inflammation markers" is not a molecular target but an umbrella term for a heterogeneous group of proteins and cell markers relevant to joint inflammation[1][2][3][4][5]. Summary of key points: - This is not a single, specific target molecule, but a class/group of various markers. - These markers are of different molecular classes (e.g., glycoproteins, enzymes, cytokines). - Used as biomarkers for disease activity, clinical trial monitoring, and sometimes as therapeutic targets, but the group term itself is non-specific. - For structured information, it is necessary to indicate individual marker names rather than the plural, collective term. If you require data on a specific marker (e.g., "Fibroblast activation protein" or "CD55"), list the individual marker for accurate target annotation.

Other names

Synovial inflammation biomarkersSynovial inflammatory markersSynovial cellular and molecular markersSynovial tissue biomarkers